Literature DB >> 3540327

Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study.

W Winkelstein, D M Lyman, N Padian, R Grant, M Samuel, J A Wiley, R E Anderson, W Lang, J Riggs, J A Levy.   

Abstract

The San Francisco Men's Health Study is a prospective study of the epidemiology and natural history of the acquired immunodeficiency syndrome in a cohort of 1034 single men, 25 to 54 years of age, recruited by multistage probability sampling. At entry, June 1984 through January 1985, the seropositivity rate for human immunodeficiency virus (HIV) infection among homosexual/bisexual study participants was 48.5%. No heterosexual participants were HIV seropositive. Among homosexual/bisexual men reporting no male sexual partners in the two years before entry into the study, seropositivity was 17.6%. For those reporting more than 50 partners, seropositivity was 70.8%. Only receptive anal/genital contact had a significantly elevated risk of HIV infection. Douching was the only ancillary sexual practice that contributed significantly to risk of infection.

Entities:  

Mesh:

Year:  1987        PMID: 3540327

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  91 in total

1.  The continuing HIV epidemic among men who have sex with men.

Authors:  J A Catania; D Osmond; R D Stall; L Pollack; J P Paul; S Blower; D Binson; J A Canchola; T C Mills; L Fisher; K H Choi; T Porco; C Turner; J Blair; J Henne; L L Bye; T J Coates
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

2.  Health-related characteristics of men who have sex with men: a comparison of those living in "gay ghettos" with those living elsewhere.

Authors:  T C Mills; R Stall; L Pollack; J P Paul; D Binson; J Canchola; J A Catania
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

3.  Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies.

Authors:  J N Martin; Z Amad; C Cossen; P K Lam; D H Kedes; K A Page-Shafer; D H Osmond; B Forghani
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  HIV transmission by fellatio.

Authors:  M Quarto; C Germinario; T Troiano; A Fontana; S Barbuti
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

5.  A pilot study of immigration status, homosexual self-acceptance, social support, and HIV reduction in high risk Asian and Pacific Islander men.

Authors:  L S Lloyd; M Faust; J S Roque; S Loue
Journal:  J Immigr Health       Date:  1999-04

6.  A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic.

Authors:  Dolores Albarracín; Jeffrey C Gillette; Allison N Earl; Laura R Glasman; Marta R Durantini; Moon-Ho Ho
Journal:  Psychol Bull       Date:  2005-11       Impact factor: 17.737

Review 7.  Greater risk for HIV infection of black men who have sex with men: a critical literature review.

Authors:  Gregorio A Millett; John L Peterson; Richard J Wolitski; Ron Stall
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

8.  Cognitive and Emotional Factors Associated with Sexual Risk-Taking Behaviors Among Young Men Who Have Sex with Men.

Authors:  Tamar Goldenberg; Rob Stephenson; Jose Bauermeister
Journal:  Arch Sex Behav       Date:  2019-01-03

9.  Seroprevalence, risk factors and attitude to HIV-1 in a representative sample of lesbians in Turin.

Authors:  R Raiteri; R Fora; P Gioannini; R Russo; A Lucchini; M G Terzi; D Giacobbi; A Sinicco
Journal:  Genitourin Med       Date:  1994-06

10.  Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

Authors:  Y Furuta; K Eriksson; B Svennerholm; P Fredman; P Horal; S Jeansson; A Vahlne; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.